Zobrazeno 1 - 10
of 100
pro vyhledávání: '"type ii endometrial cancer"'
Publikováno v:
Journal of Obstetrics and Gynaecology, Vol 43, Iss 1 (2023)
The aim of the study was to systematically explore the relationships between various adipokines and risks of endometrial atypical hyperplasia (EAH), type I endometrial cancer (EC), and type II EC. We enrolled 219 patients in this study, including 39
Externí odkaz:
https://doaj.org/article/1c9c546626dc400ab735331aa2547704
Publikováno v:
Healthcare, Vol 11, Iss 24, p 3122 (2023)
Objective: Prior studies comparing minimally invasive surgery with open surgery among patients with endometrial cancer have reported similar survival outcomes and improved perioperative outcomes with minimally invasive surgery (MIS). However, patient
Externí odkaz:
https://doaj.org/article/78f969f01b0b478ca7d9c77c0c6025f4
Autor:
Nicole Spencer, Alondra Lee Rodriguez Sanchez, Rahul Gopalam, Panneerdoss Subbarayalu, Daisy M. Medina, Xue Yang, Paulina Ramirez, Lois Randolph, Emily Jean Aller, Bindu Santhamma, Manjeet K. Rao, Rajeshwar Rao Tekmal, Hareesh B. Nair, Edward R. Kost, Ratna K. Vadlamudi, Suryavathi Viswanadhapalli
Publikováno v:
International Journal of Molecular Sciences, Vol 24, Iss 24, p 17426 (2023)
Endometrial cancer (ECa) is the most common female gynecologic cancer. When comparing the two histological subtypes of endometrial cancer, Type II tumors are biologically more aggressive and have a worse prognosis than Type I tumors. Current treatmen
Externí odkaz:
https://doaj.org/article/64006e65c45b44ea84569a84e639c587
CA-125/CEA ratio as a prognostic factor in type II endometrial cancer: a single institute experience
Publikováno v:
World Cancer Research Journal, Vol 9 (2022)
Objective: Type II (non-endometrioid) endometrial cancer is less common with an incidence of 10%-20%. It has an aggressive clinical course with heterogeneous clinic pathological features. The aim of this study is to evaluate prognostic factors and su
Externí odkaz:
https://doaj.org/article/ef60e335859040c69ddce3fcc9747e8b
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Gynecologic Oncology Reports, Vol 35, Iss , Pp 100698- (2021)
Objectives: Osseous metastases (OM) in endometrial cancer (EMCA) are thought to be rare. This study aimed to address the gap in present knowledge by defining the rate of OM in endometrial cancer (EMCA) as stratified by histology and ascertaining the
Externí odkaz:
https://doaj.org/article/512a2033311842609a4d7ae03a537507
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Rahaba Marima, Rodney Hull, Mandisa Mbeje, Thulo Molefi, Kgomotso Mathabe, Abdulrahman M. Elbagory, Demetra Demetriou, Zodwa Dlamini
Publikováno v:
International Journal of Molecular Sciences, Vol 23, Iss 2, p 628 (2022)
Precision oncology can be defined as molecular profiling of tumors to identify targetable alterations. Emerging research reports the high mortality rates associated with type II endometrial cancer in black women and with prostate cancer in men of Afr
Externí odkaz:
https://doaj.org/article/42dec85ea23e4114ba5b60272bd587b5
Autor:
Katharina Bischof, Stian Knappskog, Ingunn Stefansson, Emmet Martin McCormack, Jone Trovik, Henrica Maria Johanna Werner, Kathrine Woie, Bjorn Tore Gjertsen, Line Bjorge
Publikováno v:
BMC Cancer, Vol 18, Iss 1, Pp 1-10 (2018)
Abstract Background Uterine serous carcinoma (USC) is a rare but aggressive subtype of endometrial carcinoma. Large-scale comprehensive efforts have resulted in an improved molecular understanding of its pathogenesis, and the p53 pathway has been pro
Externí odkaz:
https://doaj.org/article/f53cfa8ac5894d4e8a1f60d2661c188f